Management Guidelines of Rheumatoid Arthritis Consensus 2016

Authors

  • Raúl Alpízar Campos Caja Costarricense de Seguro Social, Hosptal "Dr. Maximiliano Peralta Jiménez"
  • José Francisco Díaz Coto Caja Costarricense del Seguro Social, Hospital México
  • José Manuel Vega Ortiz Caja Costarricense del Seguro Social, Hospital México
  • Pablo Monge Zeledón
  • Dina Arrieta Vega Caja Costarricense del Seguro Social, Hospital México
  • Ricardo Sáenz Castro Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia

DOI:

https://doi.org/10.51481/amc.v59i3.968

Keywords:

rheumatoid arthritis, management guides, clinimetrics, biological therapy

Abstract

Rheumatoid arthritis continues to represent an important factor of deterioration in the health of people suffering from this condition despite recent medical advances in their treatment. Additionally, its significant social and economic impact it is recognized. The Costa Rican Association of Rheumatology published in 2010 the first guidelines for the management of this disease. In the present work, this first document is updated, through an exhaustive review of the available and relevant scientific information to date. This review aims to standardize and optimize the care of rheumatoid arthritis in Costa Rica. It includes recommendations for evaluation of patients, follow-up and treatment. There is also a review of drug options available in the country, i.e., symptoms-modifying drugs, conventional disease modifying drugs, as well as biological agents and small molecules.

Downloads

Download data is not yet available.

References

Raza, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005; 7:R784-95.

Van Nies, et al. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 2013; 229:286-97.

Mchold, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford) 2007;46: 342-9.

Gossec, et al. Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 2004; 63:675-8.

Downloads

Published

2017-08-30 — Updated on 2017-08-30

Versions

Issue

Vol. 59 No. 3 (2017): Acta Médica Costarricense Julio-Septiembre 2017

Section

Opinión

License

Copyright (c) 2017 Acta Médica Costarricense

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)

How to Cite

Management Guidelines of Rheumatoid Arthritis Consensus 2016. (2017). Acta Médica Costarricense , 59(3), 103-109. https://doi.org/10.51481/amc.v59i3.968